Share:
Peer-Reviewed Publication
Thorax2026June 3, 2026Journal Article

Oxygen-enhanced MRI and multiple breath washout with Short extension reveal cystic fibrosis lung disease progression despite triple modulator therapy.

Christopher Short1,2,3, Tom Semple4,2,5, Mary Abkir4,2,3, Constantinos Efthyvoulou4, Simon Padley4,2, Mark Rosenthal4,2, Paul McNally6,7, Harm Tiddens8,9,10, Daan Caudri8,9, Marta Tibiletti11, Geoff J Parker11,12, Jane Carolyn Davies4,2,3,5
1National Heart and Lung Institute, Imperial College London, London, England, UK christopher.Short@imperial.ac.uk.
2Royal Brompton and Harefield Hospitals, Guy's and St Thomas' Hospitals NHS Trust, London, England, UK.
3Lung Clearance Index Core Facility, European Cystic Fibrosis Society, London, UK.
4National Heart and Lung Institute, Imperial College London, London, England, UK.
5Centre for Paediatrics and Child Health, Imperial College London, London, England, UK.
6Department of Paediatrics, Royal College of Surgeons in Ireland, Dublin, Ireland.
7Department of Respiratory Medicine, Children's Health Ireland, Dublin, Ireland.
8Department of Paediatric Pulmonology and Allergology, Erasmus MC -Sophia Children's Hospital, Rotterdam, Netherlands.
9Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands.
10Thirona, Rotterdam, Netherlands.
11Bioxydyn Ltd, Manchester, UK.
12Department of Medical Physics & Biomedical Engineering, University College London, London, England, UK.

Abstract

INTRODUCTION: The current cystic fibrosis (CF) care era, while hugely welcome, raises new challenges, particularly the need for more sensitive pulmonary outcome measures. Seeking further optimisation, we previously developed a Short extension to multiple breath washout measure (MBWShX) which captures previously overlooked, under-ventilated lung units but lacks regional information. Functional lung…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.